Stephenson AJ - Search Results

1

The importance of serum prostate-specific antigen testing frequency in assessing biochemical and clinical failure after prostate cancer treatment.

Ciezki JP, Reddy CA, Stephenson AJ, Angermeier K, Ulchaker J, Altman A, Chehade N, Klein EA. Ciezki JP, et al. Among authors: stephenson aj. Urology. 2010 Feb;75(2):467-71. doi: 10.1016/j.urology.2009.08.051. Epub 2009 Oct 28. Urology. 2010. PMID: 19864003

2

Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer.

Stephenson AJ, Aprikian AG, Souhami L, Behlouli H, Jacobson AI, Bégin LR, Tanguay S. Stephenson AJ, et al. Urology. 2002 May;59(5):652-6. doi: 10.1016/s0090-4295(02)01526-1. Urology. 2002. PMID: 11992834

3

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Butler EB, Teh BS, Klein EA, Kupelian PA, Roehrborn CG, Pistenmaa DA, Pacholke HD, Liauw SL, Katz MS, Leibel SA, Scardino PT, Slawin KM. Stephenson AJ, et al. JAMA. 2004 Mar 17;291(11):1325-32. doi: 10.1001/jama.291.11.1325. JAMA. 2004. PMID: 15026399

4

Variations in PSA doubling time in patients with prostate cancer on "watchful waiting": value of short-term PSADT determinations.

Ross PL, Mahmud S, Stephenson AJ, Souhami L, Tanguay S, Aprikian AG. Ross PL, et al. Among authors: stephenson aj. Urology. 2004 Aug;64(2):323-8. doi: 10.1016/j.urology.2004.03.020. Urology. 2004. PMID: 15302488

5

Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, DiBlasio CJ, Reuther A, Klein EA, Kattan MW. Stephenson AJ, et al. J Clin Oncol. 2005 Oct 1;23(28):7005-12. doi: 10.1200/JCO.2005.01.867. J Clin Oncol. 2005. PMID: 16192588 Free PMC article.

6

The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy.

Stephenson AJ, Slawin KM. Stephenson AJ, et al. Nat Clin Pract Urol. 2004 Dec;1(2):90-6. doi: 10.1038/ncpuro0056. Nat Clin Pract Urol. 2004. PMID: 16474521 Review.

7

Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.

Stephenson AJ, Kattan MW, Eastham JA, Dotan ZA, Bianco FJ Jr, Lilja H, Scardino PT. Stephenson AJ, et al. J Clin Oncol. 2006 Aug 20;24(24):3973-8. doi: 10.1200/JCO.2005.04.0756. J Clin Oncol. 2006. PMID: 16921049

8

Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy.

Simmons MN, Stephenson AJ, Klein EA. Simmons MN, et al. Among authors: stephenson aj. Eur Urol. 2007 May;51(5):1175-84. doi: 10.1016/j.eururo.2007.01.015. Epub 2007 Jan 12. Eur Urol. 2007. PMID: 17240528 Review.

9

Management of clinical stage I nonseminomatous germ cell testicular cancer.

Choueiri TK, Stephenson AJ, Gilligan T, Klein EA. Choueiri TK, et al. Among authors: stephenson aj. Urol Clin North Am. 2007 May;34(2):137-48; abstract viii. doi: 10.1016/j.ucl.2007.02.001. Urol Clin North Am. 2007. PMID: 17484919 Review.

10

Identifying patients at risk for prostate-cancer-specific mortality: implications for clinical trial design.

Stephenson AJ. Stephenson AJ. Nat Clin Pract Urol. 2007 Jul;4(7):362-3. doi: 10.1038/ncpuro0809. Epub 2007 May 8. Nat Clin Pract Urol. 2007. PMID: 17487143 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters